1-800-887-8100
COPAXONE® (glatiramer acetate injection) 40 mg/mL Logo
DOWNLOAD PRESCRIPTION & SERVICE REQUEST FORM (PSR)
MENU
Shared Solutions®
DOWNLOAD PRESCRIPTION & SERVICE REQUEST FORM (PSR)
Copaxone® is the #1 prescribed brand for relapsing MS in the US 1*

Resources from Teva for your practice and patients

Teva is committed to helping MS professionals and the relapsing MS community

VIEW CNE SERVICES

Teva offers a range of downloadable educational resources that you can share with your patients

EXPLORE RESOURCES Download Prescribing Information

Teva has created the COPAXONE iTracker® 2.0, a mobile app that allows your patients to easily track their injections

COPAXONE iTracker® 2.0

COPAXONE iTracker® 2.0

COPAXONE iTracker® 2.0 was designed based on user feedback to help patients easily track injections, set medication reminders, share injection reports, and more.

LEARN MORE
Do your patients have questions about COPAXONE®?
DOWNLOAD THIS GUIDE
Why Teva's COPAXONE® complex manufacturing process is one your patients can trust
LEARN HOW IT'S MADE
The COPAXONE iTracker® 2.0 mobile app helps your patients manage their injections
FIND OUT MORE

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

IMPORTANT SAFETY INFORMATION

COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of

You are now leaving this website

The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.

While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.

Continue to site
×